Coronado Biosciences (CNDO) Adds Dr. Harlan F. Weisman to Board of Directors
Tweet Send to a Friend
Up)
Coronado Biosciences, Inc. (Nasdaq: CNDO) announced that Harlan F. Weisman, M.D., was elected to its board of directors at its Annual Meeting of Stockholders. Dr. Weisman brings over 20 years of experience as a senior healthcare executive and physician responsible for the development, regulatory approval and launch of innovative biopharmaceutical, medical device and diagnostic products. Dr. Weisman is the former Chief Science and Technology Officer for the Johnson & Johnson (NYSE: JNJ) Medical Devices and Diagnostics Group as well as former Company Group Chairman, Research & Development for Pharmaceuticals at J&J.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Intuit (INTU) Announces Several Management Changes, Business Realignment
- Atmel (ATML) Promotes Steve Skaggs to CFO
Create E-mail Alert Related Categories
Management Changes
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
